OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Psychiatry is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Broadening the Parameters of Clinical High Risk for Psychosis	485
2024 Annual Meeting: Presidential Address	206
A New Agenda for Optimizing Investments in Community Mental Health and Reducing Disparities	142
Evaluating Associations Between Cannabis and Heroin Use	139
Treating Pathologies of the Will	133
Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia	129
Mental Health Disparities Research: An Introduction to New Directions	119
Highlights From the Residents’ Journal: December 2021	112
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?	111
A Call to Psychiatrists: Deprescription of Unnecessary Anticholinergic Medications in Schizophrenia Must Start Now	110
From Scanner to Bedside: Building Bridges in Translational Psychiatric Neuroimaging	97
Cannabis and Brain Health: What Is Next for Developmental Cohort Studies?	97
Can Neuromelanin-Sensitive MRI Provide Insight Into the Dopaminergic Pathways Contributing to Substance Use?	96
From Prediction to Action: Moving Beyond Machine Learning to Implementing Evidence-Based Perinatal Mental Health Care	94
Depression, Inflammation, and Postpartum Psychosis	94
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosi	92
Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma	88
20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis	87
Genes To Mental Health (G2MH): A Framework to Map the Combined Effects of Rare and Common Variants on Dimensions of Cognition and Psychopathology	87
On the Genetic and Environmental Relationship Between Suicide Attempt and Death by Suicide	85
Project Harmony: A Meta-Analysis With Individual Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic Stress and Alcohol or Other Drug Use Disorders	85
Neural Signatures of Pain Modulation in Short-Term and Long-Term Mindfulness Training: A Randomized Active-Control Trial	84
Intentional Drug Overdose Deaths in the United States	82
Future of Sensorimotor and Psychomotor Dysfunction in Mental Disorders: Emerging Tools, Methodological Challenges, and the Road Ahead	80
New Insights Into Psychotic Disorders	76

Trends in Prescription Stimulant, Opioid, and Benzodiazepine Use and Diversion in U.S. Adolescents	72
12-month Prevalence Estimates of Substance Use Disorders Using DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use	71
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials	71
Early Adversity and Development: Parsing Heterogeneity and Identifying Pathways of Risk and Resilience	69
An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression	68
2024 Annual Meeting: CEO and Medical Director’s Address	67
Highlights From the Residents’ Journal: September 2021	66
Correcting Overestimations in Self-Harm Visit Data	62
APA Council Reports	61
Highlights From the Residents’ Journal: September 2024	60
Older Adults are at Heightened Risk of the Effects of Cannabis Use: Response to Walaszek	59
Correction to Poirot et al.	58
Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.	56
The First Large GWAS Meta-Analysis for Postpartum Depression	56
Corrigendum to Morley et al.	56
Suicide and the Menstrual Cycle	56
Coordinate Network Mapping: An Emerging Approach for Morphometric Meta-Analysis	55
Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden	53
Neural Responses to Intranasal Oxytocin in Youths With Severe Irritability	52
Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression	52
Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia	51
Familial Risk of Postpartum Psychosis	51
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression	51
Similar Rates of Deleterious Copy Number Variants in Early-Onset Psychosis and Autism Spectrum Disorder	51
Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population	50